U.S. flag

An official website of the United States government

NM_012210.4(TRIM32):c.325C>T (p.Arg109Trp) AND not provided

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
May 11, 2022
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV003141949.3

Allele description [Variation Report for NM_012210.4(TRIM32):c.325C>T (p.Arg109Trp)]

NM_012210.4(TRIM32):c.325C>T (p.Arg109Trp)

Genes:
ASTN2:astrotactin 2 [Gene - OMIM - HGNC]
TRIM32:tripartite motif containing 32 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
9q33.1
Genomic location:
Preferred name:
NM_012210.4(TRIM32):c.325C>T (p.Arg109Trp)
HGVS:
  • NC_000009.12:g.116698067C>T
  • NG_011619.1:g.15766C>T
  • NG_021409.2:g.721991G>A
  • NM_001099679.2:c.325C>T
  • NM_001365068.1:c.2806+27704G>AMANE SELECT
  • NM_001365069.1:c.2794+27704G>A
  • NM_001379048.1:c.325C>T
  • NM_001379049.1:c.325C>T
  • NM_001379050.1:c.325C>T
  • NM_012210.4:c.325C>TMANE SELECT
  • NM_014010.5:c.2653+27704G>A
  • NP_001093149.1:p.Arg109Trp
  • NP_001365977.1:p.Arg109Trp
  • NP_001365978.1:p.Arg109Trp
  • NP_001365979.1:p.Arg109Trp
  • NP_036342.2:p.Arg109Trp
  • NP_036342.2:p.Arg109Trp
  • LRG_211t1:c.325C>T
  • LRG_211:g.15766C>T
  • LRG_211p1:p.Arg109Trp
  • NC_000009.11:g.119460346C>T
  • NM_012210.3:c.325C>T
Protein change:
R109W
Links:
dbSNP: rs776796546
NCBI 1000 Genomes Browser:
rs776796546
Molecular consequence:
  • NM_001365068.1:c.2806+27704G>A - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001365069.1:c.2794+27704G>A - intron variant - [Sequence Ontology: SO:0001627]
  • NM_014010.5:c.2653+27704G>A - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001099679.2:c.325C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001379048.1:c.325C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001379049.1:c.325C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001379050.1:c.325C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_012210.4:c.325C>T - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV003823498Revvity Omics, Revvity
criteria provided, single submitter

(ACMG Guidelines, 2015)
Uncertain significance
(May 11, 2022)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee..

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]
PMID:
25741868
PMCID:
PMC4544753

Details of each submission

From Revvity Omics, Revvity, SCV003823498.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024